AMP‐activated protein kinase (AMPK) activator A‐769662 increases intracellular calcium and ATP release from astrocytes in an AMPK‐independent manner

Abstract

Aim:To test the hypothesis that, given the role of AMP-activated protein kinase (AMPK) in regulating intracellular ATP levels, AMPK may alter ATP release from astrocytes, the main sources of extracellular ATP (eATP) within the brain. Materials and Methods:Measurements of ATP release were made from human U373 astrocytoma cells, primary mouse hypothalamic (HTAS) and cortical astrocytes (CRTAS) and wild-type and AMPK α1/α2 null mouse embryonic fibroblasts (MEFs). Cells were treated with drugs known to modulate AMPK activity: A-769662, AICAR and metformin, for up to 3 hours. Intracellular calcium was measured using Fluo4 and Fura-2 calcium-sensitive fluorescent dyes. Results:In U373 cells, A-769662 (100 μM) increased AMPK phosphorylation, whereas AICAR and metformin (1 mM) induced a modest increase or had no effect, respectively. Only A-769662 increased eATP levels, and this was partially blocked by AMPK inhibitor Compound C.A-769662-induced increases in eATP were preserved in AMPK α1/α2 null MEF cells. A-769662 increased intracellular calcium in U373, HTAS and CRTAS cells and chelation of intracellular calcium using BAPTA-AM reduced A-769662-induced eATP levels. A-769662 also increased ATP release from a number of other central and peripheral endocrine cell types. Conclusions:AMPK is required to maintain basal eATP levels but is not required for A-769662-induced increases in eATP. A-769662 (>50 μM) enhanced intracellular calcium levels leading to ATP release in an AMPK and purinergic receptor independent pathway. K E Y W O R D SA-769662, AMPK, ATP, BV-2, C2C12, cortical astrocytes, GT1-7, H4IIE, hypothalamic astrocytes, INS-1, intracellular calcium, SH-SY5Y, U373

The metabolic response to inflammation in astrocytes is regulated by nuclear factor‐kappa B signaling

“…Immunocytochemistry confirmed that mature cultures contained >99% GFAP-immunoreactive glial cells (supplementary Figure S1). As previously described (Vlachaki Walker et al, 2017), cultures were maintained in Dulbecco's Modified Eagle's Media (DMEM) containing 25 mM glucose and supplemented with 10% vol/vol fetal bovine serum ([FBS] Seralabs; UK), 200 U/ml penicillinstreptomycin and 8 mM L-glutamine. Cultures were maintained in a humidified incubator at 37 C with 5% CO 2 .…”

Brain permeable AMPK activator R481 raises glycemia by autonomic nervous system activation and amplifies the counterregulatory response to hypoglycemia in rats

“…Mitochondrial oxygen consumption rates (OCR) were measured using the XF e 96 Agilent Seahorse Extracellular Flux analyzer, as previously described (28). See supplemental methods for additional details.…”

“…Cells were grown in 96-well plates overnight and intracellular ATP concentrations were measured using the ATPlite two-step assay (PerkinElmer, UK) as per manufacturer’s instructions and as previously described (28).…”

Human primary astrocytes increase basal fatty acid oxidation following recurrent low glucose to maintain intracellular nucleotide levels

“…Cellular protein was isolated as previously described [24] with minor modifications. Briefly, for acute studies 450,000 cells, or for recurrent studies 250,000 cells were seeded on to 60 mm petri dishes and harvested at the end of experiments in 65 μl of lysis buffer.…”

“…Total ATP levels were measured using ATPlite (Perkin Elmer; #6016941) with minor modifications as previously described [24]. ATP/ADP ratios were assayed by luminescence assay (Sigma; #MAK135).…”